KAICO Ltd.
As of February 2024
| City | Year of Establishment | Founder |
|---|---|---|
| Fukuoka City | 2018 | Yamato Kenta |
| Partner VC | Latest round of Fundraising | Valuation |
|---|---|---|
| FFG Venture Business Partners Co., Ltd. | Series A | JPY 2,000 million |
- Contact Information : 092-707-4016
- info-kaico@kaicoltd.jp
- Website :
KAICO Ltd.
Program name
Deep-Tech Startups Support Program
Research theme
Research and development of base manufacturing towards commercialization of oral vaccine/feed additives for swine
Business Plan
Injectable vaccination for disease prevention in swine is one of the heavy labor burdens for pig farmers. To solve this pain, KAICO developed oral vaccines for swines, which can be mixed into pigs’ daily feed. This practical usage of the oral vaccine enables the reduction of medical equipment and inoculation costs.
In certain developing countries, growth retardation in swine caused by infectious diseases has been a notable issue due to the limited availability of vaccines.
KAICO contributes to the better productivity of local farmers in such countries by commercializing the oral vaccine as feed additives and democratizing easier disease prevention for swine.
Research Outline
In this research and development, KAICO’s objective is to reach the mass production verification phase in FY2025. To accomplish this goal, we will validate quality control measures and determine appropriate dosage and administration before introducing the product to the initial target market, which is Vietnam. In Vietnam, KAICO will assess product specifications to ensure they align with the needs of the market and achieve product-market fit.
[Main objectives]
1.Validate manufacturing procedures and quality system control to ensure compliance with regulations governing veterinary pharmaceuticals.
2.Evaluate sample production to ensure adherence to the established procedures mentioned above.
3.Verify dosage and administration through trial studies involving pigs.
| Phase | Business Area/Field | Research Period | Research Grant Amount |
|---|---|---|---|
| PCA | Food & Agricuture | 2023~2025FY | JPY 172 million |
International collaborative technology demonstration
| Countries/Regions | Collaborative activity outline |
|---|---|
| Japan, Vietnam |
In collaboration with Sojitz (a Japanese trade company), KAICO has forged a business partnership with a local distributor named GreenVet, specializing in the wholesale distribution of veterinary pharmaceutical products, in our primary target market, Vietnam. GreenVet assumes responsibility for submitting the product application to the Vietnamese relevant authorities. Once product registration is finalized, GreenVet will initiate test marketing activities with local farmers and gather feedback from consumers. |
Download this pageLast Updated : May 10, 2024